An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Chronic Hepatitis B
Interventions
DRUG

telbivudine

Trial Locations (6)

Unknown

Novartis Investigative Site (705-035), Daegu

Novartis Investigative Site , (420-717), Gyeonggi-do

Novartis Investigative Site , (405-760), Incheon

Novartis Investigative Site , (136-705), Seoul

Novartis Investigative Site , (150-590), Seoul

Novartis Investigative Site, Seoul

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY